Australia markets open in 7 hours 21 minutes

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1899-0.1101 (-8.47%)
As of 12:38PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 5.48M
Enterprise value 8.25M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.14
Price/book (mrq)0.05
Enterprise value/revenue 0.81
Enterprise value/EBITDA 0.94

Trading information

Stock price history

Beta (5Y monthly) 2.17
52-week change 3-97.16%
S&P500 52-week change 326.24%
52-week high 360.1600
52-week low 31.0800
50-day moving average 34.6568
200-day moving average 312.1642

Share statistics

Avg vol (3-month) 3452.81k
Avg vol (10-day) 32.27M
Shares outstanding 54.19M
Implied shares outstanding 64.19M
Float 82.98M
% held by insiders 17.07%
% held by institutions 110.72%
Shares short (15 May 2024) 4785.58k
Short ratio (15 May 2024) 40.39
Short % of float (15 May 2024) 40.82%
Short % of shares outstanding (15 May 2024) 40.82%
Shares short (prior month 15 Apr 2024) 41.49M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Nov 2019
Ex-dividend date 4N/A
Last split factor 21:32
Last split date 310 June 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-860.23%

Management effectiveness

Return on assets (ttm)-42.07%
Return on equity (ttm)-72.08%

Income statement

Revenue (ttm)10.25M
Revenue per share (ttm)9.45
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -101.22M
Net income avi to common (ttm)-98.59M
Diluted EPS (ttm)-122.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.05M
Total cash per share (mrq)2.36
Total debt (mrq)9.82M
Total debt/equity (mrq)9.08%
Current ratio (mrq)1.47
Book value per share (mrq)46.94

Cash flow statement

Operating cash flow (ttm)-86.67M
Levered free cash flow (ttm)-63.74M